As the Ebola outbreak continues to spread across the Democratic Republic of the Congo and reaches new provinces, researchers at the University of Oxford have launched the first human clinical trial of a vaccine designed specifically against the Bundibugyo strain. The initiative marks one of the fastest scientific responses ever mounted against this particular form of the virus.
Support quality publishing and gain unrestricted access to our full library.
Sign in / Up to your Account: